Biotechnology

Pharmaceuticals Startups Drug Development Pharmaceutical Industry Genetic Testing Pharmaceutical Companies Clinical Trials Acquisitions Research and Development Life Sciences

Peter Thiel’s 7.5% Stake Sends ETHZilla Stock Soaring

Holding 82,186 ETH worth about $349 million, ETHZilla plans to generate on-chain yield through external manager Electric Capital.

Lyten Acquires Northvolt’s European Plants to Scale Lithium-Sulfur Technology

FDA Reinstates Biologics Director Vinay Prasad Less Than Two Weeks After Resignation

MEI Pharma Deploys $110 Million in Litecoin to Anchor Treasury Reserves

Bristol Myers and Bain Capital Launch $300 Million Immunology Spinout

Adaptimmune Sells Tecelra and Late-Stage Cell Therapies to U.S. WorldMeds for $55M

FDA Flags Possible License Revocation for Sarepta’s Elevidys

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research

Sarepta Defies FDA, Keeps Duchenne Gene Therapy on the Market

Loyal Launches Largest Trial for Canine Longevity Pill

Nektar Therapeutics’ Rezpegaldesleukin Trial Success Sends Shares Up 150%

Lotte Biologics Wins Manufacturing Deal to Produce Ottimo Pharma’s Jankistomig

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

Korean Biotech Firms Mark Record Presence at BIO USA 2025

Wojcicki’s Nonprofit Tops Regeneron With $305M Bid for 23andMe

BioNTech Moves to Complete $1.25 Billion Curevac Takeover

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

BioNTech to Acquire CureVac for $1.25 Billion

Zydus Lifesciences to Acquire Agenus’ California Biologics Facilities